EMEA-002195-PIP01-17

Key facts

Invented name
Active substance
Vonapanitase
Therapeutic area
Cardiovascular diseases
Decision number
P/0368/2017
PIP number
EMEA-002195-PIP01-17
Pharmaceutical form(s)
Irrigation solution
Condition(s) / indication(s)
Prevention of arteriovenous access dysfunction
Route(s) of administration
Epilesional use
Contact for public enquiries
Proteon Therapeutics Limited
Tel. +44 1635576298
E-mail: info@proteontx.com
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating